EC Number |
Title |
Organism |
---|
3.4.23.39 | Deciphering the mechanism of potent peptidomimetic inhibitors targeting plasmepsins - biochemical and structural insights |
Plasmodium falciparum |
3.4.23.39 | Fighting malaria structureguided discovery of nonpeptidomimetic plasmepsin inhibitors |
Plasmodium falciparum |
3.4.23.39 | Flap flexibility amongst plasmepsins I, II, III, IV, and V Sequence, structural, and molecular dynamics analyses |
Plasmodium falciparum |
3.4.23.39 | Fragment-based discovery of 2-aminoquinazolin-4(3H)-ones as novel class nonpeptidomimetic inhibitors of the plasmepsins I, II, and IV |
Plasmodium falciparum |
3.4.23.39 | Hydroxyethylamine based phthalimides as new class of plasmepsin hits design, synthesis and antimalarial evaluation |
Plasmodium falciparum |
3.4.23.39 | In silico docking roselle (Hibiscus sabdariffa L.) calyces flavonoids as antimalarial against plasmepsin 1 and plasmepsin 2 |
Plasmodium falciparum |
3.4.23.39 | Overexpression of plasmepsin II and plasmepsin III does not directly cause reduction in Plasmodium falciparum sensitivity to artesunate, chloroquine and piperaquine |
Plasmodium falciparum |
3.4.23.39 | A heterogeneous enzymatic assay for quantification of plasmepsin II activity and the evaluation of its inhibitors |
Plasmodium falciparum |
3.4.23.39 | Achiral, cheap, and potent inhibitors of plasmepsins I, II, and IV |
Plasmodium falciparum |
3.4.23.39 | Active Site Contribution to Specificity of the Aspartic Proteases Plasmepsins I and II |
Plasmodium falciparum |